Funding

Molecular & cellular medicine funding opportunities

All proposals anticipating MRC expenditure greater than £3m should be discussed with the named Programme Manager - see remit.

Applicants planning to undertake next generation sequencing studies are directed to MRC's guidance on accessing HTS hubs.

Applications involving human embryonic stem cells should comply with the UK Code of Practice for Use of Human Stem Cells (PDF, 502KB) and seek approval as necessary from the UK Stem Cell Bank steering  committee for the use of human embryonic stem cell lines in the UK.

Approval from the steering committee for MRC supported research involving human embryonic stem cells is an absolute requirement before work can begin. Where prior approval has been granted, the steering committee and appropriate project approval reference should be included in the ethics section of the Je-S proposal form.

View our current open funding calls.

In addition, the MCMB wishes to encourage high-quality proposals in the following priority research areas:

  • Environmental exposure and chronic disease - develop and apply measurements of exposure and effect to improve our understanding of how the environment interacts with biology and impacts health.
  • Radiation oncology & biology - priority in fundamental and translational research relevant to human health and the treatment of cancer.
  • The Research Complex at Harwell (RCaH) - to utilise the space and facilities within the Research Complex at Harwell and those on the Rutherford Appleton Laboratory (RAL) site, including Diamond synchrotron, ISIS neutron facility, Central Laser Facility.
  • Integrative Toxicology Training Partnership - national MRC-funded programme delivered through the MRC Toxicology Unit to strengthen training, academic networking and capacity building across complementary disciplines of toxicology research.